Results 231 to 240 of about 102,446 (342)
Aims The aim of this study was to introduce a new assessment method for pharmacy students' real‐life competence in reviewing medications after obligatory advanced‐level practical internship in Finland. Methods The new medication review (MR) competence assessment method consisted of (1) a self‐assessment by pharmacy students and (2) a performance ...
Katja Leiman +5 more
wiley +1 more source
The relationship between axial length and anterior segment biometry in high axial myopic Chinese students aged 7 to 18 years. [PDF]
Zhang Z, Mu J, Yang Y, Dai Y, Duan J.
europepmc +1 more source
Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients
Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel +12 more
wiley +1 more source
A multi-centre, multi-device benchmark dataset for landmark-based comprehensive fetal biometry
Vece CD +9 more
europepmc +1 more source
Results of ocular biometry from a population-based study in detecting angle-closure disease in a clinical setting. [PDF]
Philip R +5 more
europepmc +1 more source
Paternal use of metformin and risk of major congenital malformations: A meta‐analysis of 4 studies
Abstract Metformin is the first‐line drug for the treatment of Type 2 diabetes. In 2022, a Danish registry‐based study reported a 40% increased risk of major congenital malformations following paternal exposure during spermatogenesis. This raised widespread concern about the use of metformin in males of reproductive age.
Per Damkier +7 more
wiley +1 more source
Association between refraction characteristics and anthropometrics in 7- to 10-year-old Chinese primary school students. [PDF]
Cui M +8 more
europepmc +1 more source
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar +6 more
wiley +1 more source

